All In MedTech

Device Trial Radar · NCT00643526

A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector

An Open-Label, Randomized, Validation Study to Establish That the Design, Functionality, and Ergonomic Features of the Autoinjector Conform to Defined User Needs and Intended Use for Self-Administration by Subjects With Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Psoriasis

Last checked: Nov 20, 2026Latest source record: Apr 10, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

68

Actual

Start

Dec 2007

Primary completion

Jan 2008

Study completion Jan 2008

Sponsor

Lead sponsor
Centocor, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Quintiles, Inc.
First posted
Mar 26, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate how well the autoinjector works in a group of people who are likely to use the autoinjector for injecting their medicine in the future. However, no active medicine is given by the autoinjector.

Conditions

  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Psoriasis

Interventions

  • Pre-filled Auto-injector Containing PlaceboDevice

    Participants will self-inject placebo subcutaneously at thigh and abdomen.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To establish that the autoinjector, as designed, meets defined user needs and intended use for self administration by patients with RA, PsA, AS, and psoriasisTime frame: Day 1

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Miami, Florida

  • Site not named

    Duncansville, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.